HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 370.50
Day range
kr 372.00 - kr 380.00
Year range
kr 205.50 - kr 385.50
Market cap
11.91B SEK
Avg Volume
67.10K
P/E ratio
113.96
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 155.74M | 18.42% |
Operating expense | 132.15M | 39.83% |
Net income | 68.47M | 9,228.88% |
Net profit margin | 43.97 | 7,751.79% |
Earnings per share | 2.71 | 3,246.91% |
EBITDA | -1.68M | -134.90% |
Effective tax rate | -4.44% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 546.09M | 121.50% |
Total assets | 2.20B | 26.69% |
Total liabilities | 250.57M | -17.29% |
Total equity | 1.95B | — |
Shares outstanding | 31.50M | — |
Price to book | 6.00 | — |
Return on assets | -1.68% | — |
Return on capital | -1.90% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 68.47M | 9,228.88% |
Cash from operations | 18.13M | -16.81% |
Cash from investing | -52.58M | 31.76% |
Cash from financing | -3.73M | -33.07% |
Net change in cash | -48.17M | 29.17% |
Free cash flow | -49.32M | -389.35% |
About
Founded
1998
Website
Employees
148